NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0660
+0.0010 (1.54%)
Jul 15, 2026, 10:43 AM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 21.62 million as of July 14, 2026. Its market cap has decreased by -40.91% in one year.
Market Cap
21.62M
Enterprise Value
15.26M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 21.62M, an increase of 30.57%. That is a compound annual growth rate of 3.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 21.62M | -40.91% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 33.86M |
| Noxopharm | 27.96M |
| Patrys | 26.66M |
| Algorae Pharmaceuticals | 26.33M |
| Neurotech International | 22.40M |
| EZZ Life Science Holdings | 21.18M |
| Argenica Therapeutics | 16.06M |
| Immuron | 14.05M |